March – Multiple Myeloma Awareness Month

March – Multiple Myeloma Awareness Month

March is internationally recognized as Multiple Myeloma Awareness Month, a type of blood cancer that affects plasma cells – immune system cells responsible for producing antibodies and defending the body against infections.

This period provides an important opportunity to raise public awareness, highlight the challenges faced by patients, and enhance understanding of the disease, early diagnosis, and the importance of access to modern treatments.

What is Multiple Myeloma

Multiple myeloma develops in the bone marrow, when plasma cells grow uncontrollably and produce abnormal proteins. The presence of these cells can affect the production of healthy blood cells, cause bone damage, and impair the function of vital organs such as the kidneys. Although relatively rare, it is the second most common blood cancer worldwide.

The disease’s symptoms may be initially nonspecific and develop gradually. Fatigue, bone pain – especially in the spine or ribs – frequent infections, anemia, or kidney problems are some of the signs that may prompt further investigation. Early awareness and timely medical evaluation are therefore crucial for diagnosis and disease management.

Multiple Myeloma by the Numbers

Globally, the disease affects a significant number of people. According to international epidemiological data:

  • 188,000 new cases were reported worldwide in 2022

  • Approximately 121,000 people died from the disease the same year

  • It is estimated that more than 540,000 people are currently living with multiple myeloma worldwide

The disease occurs more often in older adults. Most diagnoses occur in people over 60–65 years old, and around 80% of cases are reported in individuals over 65. Experts predict that the disease’s incidence may rise in the coming decades, largely due to the aging population in many countries.

The Situation in Greece

In Greece, the exact epidemiological picture of multiple myeloma is not fully clear, as there is no comprehensive national cancer registry recording all cases systematically.

However, according to available international estimates for 2022:

  • About 763 new multiple myeloma cases were reported in the country

  • Approximately 579 deaths were attributed to the disease

  • It is estimated that around 2,154 people in Greece are living with the disease over a five-year period

These figures highlight the importance of improving health data collection and continuously supporting patients living with the disease.

Advances in Treatments

In recent years, scientific progress has significantly changed the course of the disease.

Modern therapies include:

  • Immunotherapies

  • Monoclonal antibodies

  • Proteasome inhibitors

  • Immunomodulatory drugs

  • CAR‑T cell therapies (for advanced stages of the disease)

New therapeutic combinations and ongoing clinical studies are providing more treatment options, reinforcing hope for even more effective therapies in the future.

The Importance of Awareness and Support

Despite these advancements, public awareness and support for people living with the disease remain crucial. Early diagnosis, access to specialized medical care, and equitable access to modern therapies are key factors in improving disease outcomes and patients’ quality of life.

Multiple Myeloma Awareness Month serves as a reminder that knowledge, research, and collective effort can make a difference. Through education, support for scientific research, and assistance to patients and their families, we can help create an environment where no one faces cancer alone.

Sources:

https://gco.iarc.fr
(Global Cancer Observatory – International Agency for Research on Cancer)

https://pubmed.ncbi.nlm.nih.gov/39658225/
(Global burden and projections of multiple myeloma)

https://www.oecd.org/health/cancer-profiles/greece.html
(EU Country Cancer Profile – Greece)

https://ehoonline.biomedcentral.com/articles/10.1186/s40164-025-00684-x
(Global epidemiology of multiple myeloma)

https://pmc.ncbi.nlm.nih.gov/articles/PMC3627436/
(Multiple myeloma epidemiology study)

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Continuing the Journey: Online Group Sessions for Mental Health and Nutrition – Third Cycle with Kapa3 and the LB.H.Sc

Following the warm response to the second cycle of meetings (see the related article here ), focusing on Nutritional Guidance and Experiential Psychological Support, Kapa3 and the Laboratory of Basic Health Sciences (LB.H.Sc), Department of Nursing University of Peloponnese are delighted to continue their collaboration with a third series of online group sessions for mental health and nutrition, dedicated to the holistic care of body and mind, designed for people living with cancer and their caregivers.

In this third cycle, mental health and nutrition are approached as two complementary sides of the same care.

The mental health sessions help participants recognize and manage challenging emotions such as anxiety, fear, sadness, or guilt, strengthen resilience, and cultivate a deeper connection with themselves and others.

The nutrition sessions explore how mindful and balanced eating can support the body, improve energy and mood, and become a meaningful act of self-care. Food is not only a necessity but also a way to nurture the body, mind, and spirit.

Program of Online Sessions for Mental Health and Nutrition & Themes

  • Saturday, February 28, 2026, 17:30–19:00
    Myths and truths about “anti-cancer” diets. How to evaluate nutritional information and avoid risky practices.

  • Saturday, March 14, 2026, 17:30–19:00
    Stress and uncertainty: practical ways to manage them during treatments and exams.

  • Saturday, March 21, 2026, 17:30–19:00
    Giving space to emotions without being overwhelmed: recognizing and expressing fear, anger, sadness, and guilt.

  • Saturday, March 28, 2026, 17:30–19:00
    Nutritional support during treatment & the role of cachexia.

  • Saturday, April 25, 2026, 17:30–19:00
    Boundaries without guilt: protecting energy and mental resilience.

  • Saturday, May 9, 2026, 17:30–19:00
    Safe cooking practices & kitchen hygiene.

  • Saturday, May 23, 2026, 17:30–19:00
    Family and illness: changes in relationships and ways to support each other.

  • Saturday, June 6, 2026, 17:30–19:00
    The Tree of Life: who I am beyond the illness.

  • Saturday, June 13, 2026, 17:30–19:00
    What gives meaning to life now: discovering small but meaningful elements that sustain us.

Format & Participation

The meetings are held online, based on dialogue, experiential learning, and the sharing of personal experiences. Everyone participates at their own pace, in a warm environment of acceptance and trust. Consistent attendance helps build safety and confidence within the group.

To express your interest or join the first session of the third cycle (Saturday, February 28, 17:30–19:00): [Registration Link]

Text/adaptation: Ifiyenia Anastasiou for Kapa3

World Cancer Day: United by Our Uniqueness

Every year on 4 February, World Cancer Day invites us to reflect on one of the greatest challenges of modern public health.

The goal is not only to confront cancer as a disease, but to face it with knowledge, empathy and shared responsibility. Because cancer touches millions of lives in countless ways, yet it does not define who we are. We are more than a diagnosis, more than a number.

World Cancer Day was established in 2000, following the World Summit Against Cancer for the New Millennium in Paris. It is a core element of the Paris Charter Against Cancer — a global commitment to advancing research, prevention, patient care, awareness and international mobilisation. Since then, the day has served as a reminder that addressing cancer requires long-term vision, cooperation and consistency.

This year’s message, “United by Unique”, highlights a fundamental truth: cancer is not only a medical event.

It is a deeply personal experience. Behind every diagnosis lies a unique human story — stories of fear and loss, but also of resilience, care, love and healing. Every story counts.

Cancer Today: Facts and Challenges

Cancer remains one of the most significant public health challenges in Europe and in Greece. Data from international and European organisations underline not only the scale of the disease, but also the persistent inequalities in prevention, early detection and access to care.

In Europe, approximately 2.7 million new cancer diagnoses are recorded each year, with around 1.3 million deaths, while the economic burden exceeds €93 billion annually. In Greece, cancer is the second leading cause of death, affecting thousands of families and carrying profound social and psychological consequences.

Progress, Prevention and Hope

At the same time, scientific progress offers well-founded reasons for optimism.

Prevention and early detection remain decisive factors. Screening programmes, vaccination, healthy lifestyle choices and access to reliable information can significantly reduce the risk of certain cancers and improve treatment outcomes. In this context, knowledge is not merely information — it is power and a fundamental right.

Advances in cancer management are equally important. Personalised medicine, targeted therapies, immunotherapy and improved management of treatment side effects contribute not only to increased survival rates, but also to a better quality of life for people living with and beyond cancer. Information and education are key tools for both prevention and empowerment.

Mental health plays a crucial role as well. Diagnosis and treatment are often accompanied by anxiety, fear, sadness and emotional exhaustion — affecting not only patients, but also their caregivers. Psychosocial support, counselling services and empowerment groups are essential components of holistic cancer care, helping to preserve dignity and quality of life.

Information, research and mental health care are core pillars of modern cancer management. Indicatively, you may explore the following Kapa3 articles:

Empowerment and Action

World Cancer Day is not just a day of awareness. It is a call to action:

  • to speak openly about prevention and our health,

  • to support people living with cancer and their caregivers,

  • to seek reliable information and evidence-based sources,

  • to advocate for equal access to care and psychological support,

  • to remember that no one should face cancer alone.

Because our strength lies in solidarity — and in respecting the uniqueness of every individual.

United by our uniqueness.

References:

World Health Organization (WHO) – Cancer
https://www.who.int/health-topics/cancer

International Agency for Research on Cancer (IARC)
https://www.iarc.who.int

Union for International Cancer Control (UICC) – World Cancer Day
https://www.worldcancerday.org

European Commission – Europe’s Beating Cancer Plan
https://health.ec.europa.eu/eu-policy/health-strategies/europes-beating-cancer-plan_en

European Cancer Information System (ECIS)
https://ecis.jrc.ec.europa.eu

Hellenic Statistical Authority (ELSTAT) – Health Data
https://www.statistics.gr/en/statistics/-/publication/SHE15/

Hellenic National Public Health Organization (EODY) – Cancer & Public Health
https://eody.gov.gr/

Greek Ministry of Health – Prevention & Screening
https://www.moh.gov.gr/articles/prevention-screening

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Disability Card in Greece: What You Need to Know

The Disability Card was established under Law 4961/2022 (FEK A’ 146, Article 106) and is regulated by Ministerial Decision 16996/2023 (FEK B’ 932/23-02-2023).
It serves as a unified proof of identity and disability, which must be accepted by all public and private entities.

Read the text of Ministerial Decision 16996/2023 (Article 20) here.

In short, the Disability Card offers:

  • Proof of disability without the need to show medical certificates or documents from KEPA.

  • Priority service at public offices, utilities, banks, and hospitals.

  • Free or reduced access to museums, archaeological sites, and cultural events for the cardholder and their companion.

  • Use of special facilities (e.g., seats or parking spaces for people with disabilities).

  • Mutual recognition of the Card in EU countries where an agreement exists.

Card format

The Card is digital, but it can also:

  • Be saved as a PDF,

  • Be printed,

  • Be added to the Gov.gr Wallet,

  • And will soon be available in a plastic card format.

How to obtain it

The process is simple:

  1. Visit the National Disability Portal here: karta.epan.gov.gr

  2. Log in with your Taxisnet credentials.

  3. If a valid disability certificate exists, the Card is issued immediately.

  4. The same process applies for minors or companions using their respective Taxisnet credentials.

Applications for the plastic disability card began on November 18, 2025. The process is carried out as described above (through the National Disability Portal), and the plastic card is sent by registered mail within a two-week period.

For any inquiries, you can call: Helpdesk 210-3007606 or send an email to: helpdesk@epan.gov.gr

KAPA3 continues to stand by cancer patients and their families, offering reliable guidance and practical support so that every patient feels safe and fully informed about their rights and benefits.

For oncology patients who want detailed information on all the exemptions and benefits they are entitled to, KAPA3 has compiled a complete guide in the “Exemptions and Benefits” section of its website here.

Text/adaptation: Ifiyenia Anastasiou for KAPA3

 

 

Digital transformation: Health systems’ investment priorities

Health systems around the world are facing a host of challenges, including rising costs, clinical-workforce shortages, aging populations requiring more care (for example, to treat chronic conditions), and increasing competition from nontraditional players.1 At the same time, consumers are expecting new capabilities (such as digital scheduling and telemedicine) and better experiences from health systems across their end-to-end care journeys.2 In response, health systems are increasing their focus on digital and AI transformation to meet consumer demands, address workforce challenges, reduce costs, and enhance the overall quality of care.3 However, despite acknowledging the importance of these efforts to future sustainability, many health system executives say their organizations are still not investing enough.

AI, traditional machine learning, and deep learning are projected to result in net savings of up to $360 billion in healthcare spending.

AI, traditional machine learning, and deep learning are projected to result in net savings of $200 billion to $360 billion in healthcare spending.4 But are health systems investing to capture these opportunities? We recently surveyed 200 global health system executives about their digital investment priorities and progress.5 Seventy-five percent of respondents reported their organizations place a high priority on digital and analytics transformation but lack sufficient resources or planning in this area.

Increasing prioritization

In line with other industries, the majority (nearly 90 percent) of health system executives surveyed, in both technical roles (such as chief information officer or chief technology officer) and nontechnical roles (for example, CEO or CFO), reported that a digital and AI transformation is a high or top priority for their organization. At the same time, 75 percent of respondents reported their organizations are not yet able to deliver on that priority because they have not sufficiently planned or allocated the necessary resources.


Health system digital investment priority areas and anticipated impact

For health system executives, current investment priorities do not always align with areas they believe could have the most impact. There is alignment in some areas, including virtual health and digital front doors, where about 70 percent of respondents expect the highest impact.1 In other areas, such as AI, 88 percent of respondents reported a high potential impact,2 yet about 20 percent of respondents do not plan to invest in the next two years. The absence of investment in a robust, modern data and analytics platform could delay value creation in areas that depend on these capabilities—such as efforts to close gaps in care, improve timely access for referrals, and optimize operating room throughput.

Major headwinds and slow progress

Given the current macroeconomic climate and increasing cost pressures on health systems, most respondents identified budget constraints as a key obstacle to investing at scale across all digital and AI categories of interest (51 percent of respondents ranked this obstacle among the top three). For example, a health system that is building a digital front door may lack the resources to simultaneously invest in the latest generative AI (gen AI) capabilities.

Respondents called out challenges with legacy systems as the second-greatest concern (after budget constraints). Core tech modernization is key to delivering on the digital promise,1 but health systems have typically relied on a smaller set of monolithic systems that have become a challenge to untangle.

Additional highly ranked challenges include data quality (33 percent), tech talent and recruiting (30 percent), and readiness to adopt and scale new technology (34 percent).

Satisfaction with digital investment

Most executives of health systems that have invested in digital priorities (72 percent) reported satisfaction across all investment areas. Among the comparatively fewer respondents who reported investing in robotics and advanced analytics, satisfaction was even higher, at 82 percent and 81 percent, respectively. Given that investments result in a high level of satisfaction and that 75 percent of executives reported they are not yet able to deliver on their digital transformation ambitions (as noted above), health systems may be facing a failure to scale their digital programs.

What health systems can do and how they can learn from other industries

The goal of digital and AI transformation is to fundamentally rewire how an organization operates, building capabilities to drive tangible business value (such as patient acquisition and experience, clinical outcomes, operational efficiency, and workforce experience and retention) through continuous innovation. Delivering digital value for health systems requires investment and new ways of working.

Building partnerships. Scale is crucial to value creation. But the definition of at-scale systems has changed in the past few years; today, it takes more than $13 billion to be a top 20 system by revenue, and many have reached their current position through inorganic growth.6 Partnerships (joint ventures and alliances) may offer a promising avenue to access new capabilities, increase speed to market, and achieve capital, scale, and operational efficiencies.7

Moving beyond off-the-shelf solutions. History shows that deploying technology—such as electronic health records (EHRs)—on top of broken processes and clinical workflows does not lead to value. Realizing value from healthcare technology will require a reimagination (and standardization) of clinical workflows and care models across organizations. For example, optimizing workflows to enable more appropriate delegation, with technical enablement, could yield a potential 15 to 30 percent net time savings over a 12-hour shift. This could help close the nursing workforce gap by up to 300,000 inpatient nurses.8

Using the cloud for modernization. Health systems are increasingly building cloud-based data environments with defined data products to increase data availability and quality. Health systems can also use cloud-hosted, end-user-focused platforms (such as patient or clinician apps) that integrate multiple other applications and experiences to simplify stakeholders’ interactions with the system.

Operating differently. Operating differently entails fundamental changes in structure (flatter, empowered, cross-functional teams), talent (new skill sets and fully dedicated teams), ways of working (outcome orientation, agile funding, and managing products, not projects), and technology (modular architecture, cloud-based data systems, and reduced reliance on the monolithic EHR). With these changes, some health systems have begun to see real value within six months. Building a digital culture helps the transformation succeed over time.9

Cautiously embracing gen AI. Gen AI has the potential to affect everything from continuity of care and clinical operations to contracting and corporate functions. Health system executives and patients have concerns about the risks of AI, particularly in relation to patient care and privacy. Managing these risks entails placing business-minded legal and risk-management teams alongside AI and data science teams.10 Organizations could also implement a well-informed risk-prioritization strategy.

Digital and AI investments provide health systems with opportunities to address the many challenges they face. Successful health systems will invest in areas with the greatest potential impact while removing barriers—for example, by upgrading legacy infrastructure. Health systems that make successful investments in digital and analytics capabilities could see substantial benefits and position themselves to benefit from the $200 billion to $360 billion opportunity.11

ABOUT THE AUTHOR(S)
Jack Eastburn is a partner in McKinsey’s Southern California office; Jen Fowkes is a partner in the Washington, DC, office; and Karl Kellner is a senior partner in the New York office. Brad Swanson is a consultant in the Denver office.

The authors wish to thank David Bueno, Camilo Gutierrez, Dae-Hee Lee, Audrey Manicor, Lois Schonberger, and Tim Zoph for their contributions to this article.

Πηγή: mckinsey.com
find more :https://eefam.gr/digital-transformation-health-systems-investment-priorities/

Discovering the multi-level contribution of AI to the NHS

Following the recent announcement of increased funding for artificial intelligence within the NHS by the Chancellor in the Spring 2024 programme highlights the importance of stabilising the healthcare system and securing the leading position in healthcare delivery on a global scale. In order to maximise the patient benefit and staff satisfaction through the full utilisation of the use of AI, it is useful to develop an action plan with proactive next steps.

Step 1: Focus on the right priorities

There are many high-impact use cases such as waiting list management. By developing AI algorithms and data-driven decision support tools to predict patient demand, optimize scheduling, and efficient allocation of resources, healthcare facilities can significantly reduce wait times and enhance patient satisfaction. Through our work with NHS Trusts it has been shown that the development of AI-based programming tools has resulted in An increase in patient preference within imaging. Artificial intelligence can also help to enhance the support of  office services. Experience so far has shown a significant reduction in the time to review a contract with the use of artificial intelligence.

Step 2: Cultivating staff acceptance

An important aspect of any AI initiative is cultivating trust and acceptance from frontline staff. As clinicians focus on refining their clinical judgment and providing personalized care it makes sense that they approach the integration of AI with caution. To avoid this hesitation it is important that strict trials of an evidence-based implementation. Furthermore, the syndrome of ”that it was not manufactured here” prevents and forces individual executives to actively engage and convince their clinical communities of tangible evidence of AI adoption. One approach to fostering staff buy-in is active involvement from the outset in the design of the programme design.  The use of the “Net Promoter Score”, which measures staff enthusiasm for a particular technology, is a strong incentive for engagement and could potentially help. Also in cases where staff know that the technology is supported by their colleagues, after a pilot project, it is more more likely to want to participate themselves. Another useful approach is for the clinician to present his or her own prediction alongside any AI prediction, allowing the staff to make their own prediction to immediately see how the AI compares. Using this method, we can show that an AI algorithm was more predictive of the day a patient would be ready to leave than the clinician’s own estimate.

Step 3: Integrating the technology into the standard

Considering a user-driven approach to process redesign has the dual impact of bring the affected parties – for example, staff, patients and carers – together on the journey, while also helping to ensure that change is not just a digitisation of existing processes. THE NHS will need to fund the effort so that by supporting staff to trust and find the budget to deliver the necessary change programme.

Looking forward: A collaborative imperative

Vital to the whole effort will be the collaboration between government, the NHS leadership, frontline staff and the technology partners. Latest research has shown that 74% of organisations recognize that AI can make their operations more efficient, and a staggering 84% do not believe they are equipped to do so to make it a reality. While the Chancellor’s investment in AI represents a significant moment, the result is testament to how capable we are of navigating the complexities of implementation effectively and provide frontline organisations with the support they need.

Read more: Transforming through Data,page 116 Article from Jenny Lewis under the title ”  Unlocking the Potential of AI in the NHS: A Path Forward’

H.M._2-vol 24-2024 (1)

Kapa3 – Social Message for Public Awareness and Education on Cancer

The Kapa3’s social message for public awareness and education on cancer has gone viral! A powerful message that captures the attention of thousands of citizens daily on social media.

Continuing its successful effort to raise public awareness about the importance of social support and its impact on managing chronic illnesses, Kapa3 created a television and radio spot emphasizing the need for timely and appropriate social support from the right people—especially in an era where globalization and rapid lifestyle changes pose major challenges to healthcare professionals and the community in cancer management.

The spot, titled “Think of a Word That Starts with K”, engages and captivates thousands of citizens daily, with its reach steadily growing. This multifaceted social message was posted online as part of a campaign created by Kapa3 to inform and raise awareness. The message has already surpassed 100,000 views, reinforcing Kapa3’s mission: social support and guidance for cancer patients navigating the challenging path of their illness.

This initiative is a strong call to social responsibility, encouraging everyone to actively participate in the ongoing effort to support healthcare services, improve cancer patients’ quality of life, promote prevention principles, engage the public in health management, reduce human and financial costs, and highlight civil society as a positive driver for public-benefit actions.

A key prerequisite for all this is the establishment of a strong, supportive social, institutional, and legal framework that safeguards patients’ fundamental right to a life free from stereotypes and discrimination.

Notably, the spot, produced with a focus on promoting public health and social support, was approved by the Greek National Council for Radio and Television (ESR). Following the approval of its Special Three-Member Committee for Social Messages (Decision 207-09.11.2023), the spot was authorized for free broadcast on television and radio stations nationwide from December 1 to December 31, 2023.

The campaign was made possible thanks to the unwavering support of friends, partners, volunteers, and Kapa3 members under the guidance of A3, and has been promoted across Greece and online through the organization’s initiatives.

We are sharing it with you online so that it can be featured by local media, spreading the message that “Not only Cancer Starts with K, but also everything that can defeat it”, leading the way in public education and awareness.

According to Mattson (2011), building on definitions by Albrecht & Adelman (1987) and Gottlieb (2000), social support is defined as “a transactional, communicative process involving verbal and non-verbal interaction aimed at enhancing an individual’s perception of their ability to manage their problem, self-esteem, and sense of belonging.”

We sincerely thank you for your positive response and support.

Evangelí Bista
Head of Development and Operations, Kapa3
PhD(c), MBA, MSc, BSc
Mobile: +30 697 410 2934

Digital-in-Health: Unlocking the Value for Everyone

Digital technology can strengthen health systems, improve health financing and public health, and increase reach to underserved populations, according to a new World Bank report launched today. The report also finds that digital technology and data are especially helpful to prevent and manage chronic diseases, care for both young and aging populations, and prepare for future health emergencies and health risks triggered by climate change.

The report, Digital-in-Health: Unlocking the Value for Everyone, was launched today during the G20 Health Ministers Meeting in Gandhinagar, India. It presents a new way of thinking from simple digitization of health data to fully integrating digital technology in health systems: Digital-in-health. This means, for example, infusing digital technologies in health financing, service delivery, diagnostics, medical education, pandemic preparedness, climate and health efforts, nutrition, and aging.

The report also underscores that the successful use of digital technologies must be inclusive of all population groups, and ensure access to digital infrastructure, modern technologies, and skills, especially for vulnerable people.

Designed with people at the center, digital technology can make health services more personal, prevent healthcare costs from increasing, reduce differences in care, and make the job easier for those who provide health services,” said Mamta Murthi, Vice President for Human Development, World Bank. “We hope that this report will give governments confidence and practical guidance, regardless of the country’s stage of digital maturity or fiscal challenges.

Improving health is getting harder, not easier. Health systems face serious and growing challenges and policy decisions are too often not based on reliable data.  It is estimated that some countries use less than 5% of health data to improve health which means that decisions are not based on data or data is not used effectively to make improvements. Within challenging fiscal environments, people-centered and evidence-based digital investments can help governments save up to 15% of health costs. The report presents pragmatic, low-cost actions to improve digital-in-health, no matter the maturity of a country’s systems or digital infrastructure. For example, better health data governance and standards to ensure systems can readily connect and exchange information are not costly but will be game changing in reducing siloed digital solutions and fragmentation.

In India, we have shown that digital innovations such as tele-consultations have reached more than 140 million people and provided accessible, affordable and efficient healthcare for everyone,” said Mansukh L Mandaviya, Minister for Health and Family Welfare, India. “We believe a digital-in-health approach can unlock the value of digital technologies and data and has the potential to prevent disease and lower healthcare costs while helping patients monitor and manage chronic conditions.” 

 

To help countries embrace a digital-in-health approach, the report proposes three essential areas to guide investments:

  1. Prioritizeevidence-based digital investments that tackle the biggest problems and focus on the needs of patients and providers.
  2. Connect the regulatory, governance, information, and infrastructure dots so that patients know that data is safe and health workers can use digital solutions transparently.
  3. Scale digital health for the long run based on trust with sustainable financing, and improved capacity and skills for digital solutions.

It will take global, regional, and country leadership to make digital-in-health a reality. The report recommends strong country leadership involving all relevant sectors and stakeholders, including civil society. Digital technology and data improvements will involve investments beyond the health sector and new partnerships with the private sector. A digital-in-health mindset needs to be a routine aspect of annual health system planning, budgeting, and implementation.

The World Bank is committed to helping low-and middle-income countries to make digital-in-health a reality to improve health for everyone. Over the past decade, the World Bank has invested almost $4 billion in digital health including in health information systems, digital governance, identification systems, and infrastructure.

For more information, including a copy of the new report, Digital-in-Health: Unlocking the Value for Everyone, please visit:

Website: www.worldbank.org/en/topic/health

Twitter: http://www.twitter.com/WBG_Health

Facebook: http://www.facebook.com/worldbank

YouTube: http://www.youtube.com/worldbank

 

Conceptualizing the Mechanisms of Social Determinants of Health: A Heuristic Framework to Inform Future Directions for Mitigation

A large body of scientific work examines the mechanisms through which social determinants of health (SDOH) shape health inequities. However, the nuances described in the literature are infrequently reflected in the applied frameworks that inform health policy and programming.

We synthesize extant SDOH research into a heuristic framework that provides policymakers, practitioners, and researchers with a customizable template for conceptualizing and operationalizing key mechanisms that represent intervention opportunities for mitigating the impact of harmful SDOH.

In light of scarce existing SDOH mitigation strategies, the framework addresses an important research-to-practice translation gap and missed opportunity for advancing health equity.

Conceptualizing the Mechanisms of Social Determinants of Health!

I. SDOH
Health inequities are most often understood as associated with the social determinants of health (SDOH)

II. Opportunity
A practical, heuristic framework for policymakers, practitioners, and researchers is needed to serves as a roadmap for conceptualizing and targeting the key mechanisms of SDOH influence

  • Unifying principles

1. SDOH are underlying causes of health inequities
-> Meaningful community engagement in data generation and interpretation for understanding and mitigating underlying health inequity drivers and multilevel resilience factors

2. SDOH shape health inequities through contextual influences
-> Development, evaluation, and scale up of multilevel interventions that address the mechanisms of SDOH at the structural, psychosocial, and clinical/biomedical levels

3. SDOH contextual disadvantage is not deterministic
-> Adoption of individualized/differentiated, decentralized, and community-based service delivery models

4. SDOH shape health over the life course
-> Proactive intervention focused on prevention and health promotion as well as restorative care to maintain and improve physical, mental, and psychosocial functioning and quality of life

5. SDOH operate through biological embedding
-> Greater prioritization of harmful SDOH mechanisms and mitigation of their biological impact in clinical education and practice, including investment in biomarkers for early detection of and intervention on emerging disease trajectories

6.SDOH operate intergenerationally
-> Prioritization of family-based approaches to restorative health care, prevention, and health promotion

7. SDOH shape clustering and synergies of health inequities
-> Greater integration of comprehensive, interdisciplinary, team-based health services delivered within a value-based framework and at the top of providers’ licenses

8. SDOH mechanisms to produce health inequities
-> Departure from vulnerability- and deficiency-focused paradigms for understanding health inequities toward multilevel resilience-focused paradigms for reducing health inequitiess

An Organizing Framework of SDOH Mechanisms

1. Underlying causal factors
-> Two distinct classes of social influence: SDOH capital and SDOH processes

2. Mediating factors
-> Two mechanisms: environmental and behavioral exposure and biological susceptibility

3. Moderating factors
-> Resilience – as collective action that supports the ability of communities to thrive when confronted with structural challenge

4. Health inequity outcomes
-> The impact of SDOH mechanisms on health inequities is dependent on the broader patterns of morbidity within the community of interest

Check out the article by Marco Thimm-KaiserAdam Benzekri and Vincent Guilamo-Ramos here:

https://lnkd.in/e57GXthQ

Essential cancer screening and diagnosis services must be included in UHC schemes to reduce mortality

The earlier a cancer is detected, the easier it is to treat successfully, often with fewer side effects, and at a lower cost. In many high-income regions, such as Europe and the United States, survival rates for cancer have risen in past decades, in part thanks to routine screening that detects cancers at an early stage. It’s especially true for common cancers like cervical, breast, colorectal, and prostate, where routine screening offers a clear test and methodology for early detection.

Investing in routine screening programmes for asymptomatic cancers as well as the early detection of symptomatic cancers and diagnostic and referral services is, therefore, a cost-efficient approach to mitigate the public health costs of cancer. These are estimated to reach USD 458 billion globally by 2030, and cut the projected global economic cost of cancers, estimated at USD 25.2 trillion for the period 2020-2050.

Such investments in services must be accompanied by clear communication about the necessity and benefits of such measures. It is also critical that the general public have access to reliable information on possible early signs of certain cancers (notably, breast, cervical, lung, prostate, ovarian and testicular) and primary healthcare staff must be equipped to spot signs of cancer – with rapid referral options for screening and then treatment.

Unfortunately, many people around the world still lack access to these essential services. In low- and middle-income countries in particular, cancer prevention, diagnosis and care remain a luxury that is out of reach for many.

A significant number of people, particularly those from low-income communities, face barriers that prevent them from accessing necessary health services, such as the distance to healthcare facilities and costs of healthcare – with the risk of financial toxicity if they must be paid for out of pocket.

A weak health system and an absence of knowledgeable healthcare providers can also stand in the way of timely cancer detection and diagnosis.

To close these gaps, routine screening, cancer diagnosis and referral services must be included in health insurance benefits packages.

UHC cannot be achieved unless everyone has access to affordable cancer care. At the same time, without the benefits offered by UHC, access to potentially life-saving screenings remains limited. This means someone may die of a cancer that could have been detected and treated at an earlier stage, but either an early detection programme was not available or that person could not access it, for financial or other reasons. A cost-efficient national cancer control plan with essential services – including routine screening and diagnosis – covered by national health insurance schemes available to everyone – can break down these barriers to accessibility, availability and affordability.

Indeed, often cancer treatment by national health insurance schemes but not screening. Issues of stigma that surround many cancer tests (for instance, those that concern sexual organs) therefore compound concerns about cost or fears of a diagnosis (e.g. cancer may be considered a death sentence, so why get tested?) to prevent high numbers of people getting a timely diagnosis, resulting in many patients presenting with late-stage cancers.

At the second High-level Meeting on Universal Health Coverage taking place on 21 September 2023, Governments are expected to adopt a set of new commitments to accelerate UHC implementation. This meeting will provide an opportunity for UICC to advocate for including comprehensive cancer prevention and control measures in UHC benefits packages.

In preparation for this pivotal meeting, UICC reached out to its members to learn about their concerns and inform its advocacy strategy in the lead-up to the UN HLM on UHC.

UICC is also organising a series of Virtual Dialogues intended to facilitate discussions around UHC and its impact on cancer control. The first dialogue organised in early May looked at UHC and prevention. A second Virtual Dialogue on UHC and early detection will take place on 20 July, and look at examples of successful advocacy to include screening and early detection in UHC benefit packages (for instance, mammography reimbursement in Algeria) and the use of legislation to support screening and early detection programmes and referral to treatment.

Read more :

https://www.linkedin.com/pulse/essential-cancer-screening-diagnosis-services-must-included-uhc-schemes%3FtrackingId=yU3y0j6Af4hHzyucBwUSyw%253D%253D/?trackingId=yU3y0j6Af4hHzyucBwUSyw%3D%3D